Fluconazole and Amphotericin B Comparison in Acute Cryptococcal Meningitis Treatment
Flucytosine
+ Fluconazole
+ Amphotericin B
Blood-Borne Infections+26
+ Neuroinflammatory Diseases
+ Urogenital Diseases
Treatment Study
Summary
This study focuses on comparing two treatments for acute cryptococcal meningitis, a serious infection that causes inflammation in the membranes surrounding the brain. The two treatments are fluconazole (UK-49,858) and amphotericin B, which may also be used in combination with another drug called flucytosine. The goal is to determine which treatment works better and is safer for individuals affected by this condition. This research is important as it aims to improve the care and treatment options for those suffering from acute cryptococcal meningitis. During the study, participants receive either fluconazole or amphotericin B, potentially along with flucytosine. The effectiveness and safety of these treatments are then evaluated. The study measures how well each treatment works in managing the infection and reducing its symptoms, as well as any potential side effects. The results of this study could provide valuable insights into the best treatment strategies for acute cryptococcal meningitis.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location